CFTR and cystic fibrosis: Concurrently, McKee and co-authors [129] compared the effects of elexacaftor and tezacaftor individually and in a double combination on the PM expression of 129 CF-causing variants using a deep mutational scanning approach to compare mutation-specific effects by these CFTR modulators.